Clinical Scorecard: Ultrasound Attenuation Imaging Tracks Hepatic Steatosis
At a Glance
| Category | Detail |
|---|---|
| Condition | Hepatic Steatosis in Pediatric Patients |
| Key Mechanisms | Ultrasound-based attenuation imaging values reflect hepatic fat-related acoustic attenuation. |
| Target Population | Children with overweight or obesity |
| Care Setting | Single-center, pediatric hospital |
Key Highlights
- Increased attenuation imaging values correlate with steatosis severity.
- Median values: 0.51 dB/cm/MHz (healthy), 0.54 (overweight), 0.64 (obesity).
- Strong association between attenuation values and steatosis grade (η² = 0.626).
- No significant correlation with sex; strongest correlation with alanine aminotransferase.
- Study limitations include lack of MRI-PDFF validation and single-center design.
Guideline-Based Recommendations
Diagnosis
- Use ultrasound attenuation imaging to assess hepatic steatosis severity.
Management
- Consider metabolic and anthropometric measures alongside imaging results.
Monitoring & Follow-up
- Regularly monitor liver function tests, including alanine aminotransferase.
Risks
- Caution against broad generalization of results due to single-center study limitations.
Patient & Prescribing Data
Children with overweight or obesity, aged 2-18 years.
Further multicenter studies needed to validate findings and establish clinical utility.
Clinical Best Practices
- Incorporate standardized protocols for attenuation imaging across different ultrasound platforms.
- Consider histologic validation in selected patients for accurate diagnosis.
References
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
